🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
CTQJ230A1US13 is a randomized, double-blind, placebo-controlled, multicente...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-31
Trial ID
NCT07625306
Treatments Being Tested
This is a pivotal phase 3 study designed to support an indication for the r...
Status
Completed
Location
SEC Clinical Research LLC
Start Date
2019-12-12
Trial ID
NCT04023552
This non-randomized, rollover extension study will provide post-trial acces...
Status
Recruiting
Location
Parkway Medical Center
Start Date
2025-05-19
Trial ID
NCT06875973
Treatments Being Tested
Phase III study to test the hypothesis that treatment with pelacarsen (TQJ2...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-08-19
Trial ID
NCT05305664
Treatments Being Tested
The purpose of this registration is to list Managed Access Programs (MAPs) ...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT07000695
Treatments Being Tested
The purpose of the study is to assess the safety, tolerability, and pharmac...
Status
Completed
Location
Parexel International
Start Date
2018-10-15
Trial ID
NCT05337878
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, dose-r...
Status
Completed
Location
Clinical Site
Start Date
2017-03-07
Trial ID
NCT03070782
Treatments Being Tested
This open-label extension study will provide post-trial access to pelacarse...
Status
Recruiting
Location
SEC Clinical Research LLC
Start Date
2026-05-11
Trial ID
NCT07517263
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Status
Recruiting
Location
Heart Center Research Llc
Start Date
2024-03-07
Trial ID
NCT05646381
Treatments Being Tested
This was a Phase I, open-label, single-dose, parallel-group study in partic...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-11-23
Trial ID
NCT05026996
Treatments Being Tested